Aceclofenac 100mg and Paracetamol 325mg Tablets
(As per ICH guidelines)
(BY HPLC)
This document is an exercise on Analytical Method Validation of the various analytical
Methods used in determination of active ingredients in Quality Control Laboratory of
“Company Name ”.
CONTENTS
Sr. No | Contents | Page No. |
A | Post-Approval | 3 |
B | Objective | 4 |
C | Method Summary | 4 |
D | Scope | 4 |
E | Responsibility | 4 |
F | Method of Analysis | 5 |
G | Summary table | 7 |
1 | Specificity | 9 |
2 | System Accuracy | 9 |
3 | Linearity | 10 |
4 | Range | 10 |
5 | Accuracy | 10 |
6 (i) | Precision-Method Precision | 14 |
6 (ii) | Intermediate Precision | 15 |
7 | Robustness | 18 |
8 | Conclusion | 19 |
CONTRIBUTIONS:
This protocol is a team effort of Quality control Laboratory chemists to achieve the objective of validating the analytical methods carried out to estimate the contents of pharmaceutical products manufactured by “Company Name ”.
- POST APPROVAL:
· Analytical
Method Validation Protocol Number |
AMV/SCT/T/003 | ||
· Validation Frequency | Analytical Methods should be re-validated after any significant change in analytical method. | ||
Designation | Name of the Person | Sign /Date | |
· Prepared By | Officer -QC |
|
|
· Checked By | Executive -QC |
|
|
· Checked By | Manager-QC |
|
|
· Approved By | Head-QA |
|
- OBJECTIVE: The efficacy & safety of a medicinal product can only be assured by analytical monitoring of its quality. This report is designed to validate the HPLC Assay Method for Aceclofenac and Paracetamol in Tablets as per ICH Guidelines for routine analysis.
- METHOD SUMMARY:
The analytical method for assay of Aceclofenac + Paracetamol Tablets by HPLC shall be validated as per ICH Guidelines for routine analysis.
- SCOPE : The Quantity determination of Aceclofenac + Paracetamol Tablets by HPLC shall be validated for following analytical and performance parameters as described in ICH guidelines.
- Specificity
- System Accuracy
- Linearity
- Range
- Accuracy
- Precision
- Robustness
- RESPONSIBILITY:
Quality Control
. To prepare the analytical method validation Report for the assay of Aceclofenac + Paracetamol . To validate the analytical method for the assay of Aceclofenac + Paracetamol tablets
. To prepare analysis record based on the results and observations.
Quality Assurance Department
. To approve the analytical method validation report.
PRODUCT DETAILS:
Product Name
|
Aceclofenac and Paracetamol Tablets |
Label Claim
Batch No. Mfg. Date Exp. Date |
Each Film Coated Tablets Contains :
Aceclofenac IP 100mg Paracetamol IP 325mg
|
- METHOD OF ANALYSIS (BY HPLC):-
Equipment required:
- HPLC system UV/Visible detector model- Agilent 1260 auto sampler , Instrument ID SC/QC/038.
- Analytical balance, Make RADWAG, Model-AUX220, Instrument ID No. SC/QC/002
- Ultrasonic cleaner, Instrument ID No. SC/QC/010.
Glass wares required:
- Volumetric Flask 100 & 50 ml
- Beaker
- Measuring Cylinder
Reagent required:
- Water (HPLC grade)
- Methanol (HPLC grade)
Working standard:
- Aceclofenac, WS ID No. WS/002, (Valid upto- 15/06/2019), Purity- 98.84% (on as such basis)
- Paracetamol WS ID No. WS/0166(Valid upto- 15/03/2019), Purity- 98.84% (on as such basis)
- Aceclofenac (100mg) and Paracetamol(325mg)(BY HPLC):–
Mobile phase: Mobile phase: – Methanol + Water + G.A.A. = 80: 20 +0.01; degas,
Column: – C-18, (150 x 4.6mm, 5µm); Wavelength: – 280nm; Flow rate: – 1.8ml per minute;
Injection volume: – 20µl;
Standard preparation: –
Weigh accurately about 162.5 mg of Paracetamol ws, and 50 mg of Aceclofenac ws in 100ml volumetric flask, dissolve in and dilute to the mark with mobile phase. Shake well and further dilute 2 ml to 50 ml with mobile phase. Shake well and filter through 0.45µm nylon filter.
- Chromatographic condition:
- Column: – C-18,( 250 x 4.6mm), 5µm,
- Wave length: – 271 nm,
- Flow rate: – 1.0 ml per minute,
- Injection volume: – 20 µl,
- Test preparation: –
- Weigh accurately about equivalent to 250 mg of Paracetamol from crushed powder of 20 tablets in 100 ml volumetric flask, add 50 ml of mobile phase, sonicate for 5 minutes, cool to room temperature.
- Temperature and dilute to the mark with mobile phase, filter. Shake well and further dilute 2 ml to 50 ml with mobile phase, shake well and filter through 0.45µm nylon filter.
- Procedure: –
- Inject separately standard and test preparation. Inject five replicate injection of test and two replicate injection of test preparation.RSD of replicate injection should not more than 2%. Calculate the assay of Paracetamol and Aceclofenac by comparison to peak area of standard preparation.
- Calculation:
- Test area ͌ 162.5mg 2 100 50
- Paracetamol = ———– x ———— x ——- x ——– x ——- x Av wt of tablet x potency of ws
- (mg/tablet) area 100 50 test wt. 2
- Test area ͌ 50mg 2 100 50
- Aceclofenac.=——— x ———– x ——– x ———– x ——- x Av wt of tablet x potency of ws
- (mg/table) area 100 50 test wt. 2
- SUMMARY TABLE:
Analytical Performance Parameters
Sr. No | Validation Parameters | Acceptance Criteria | Observations |
1. | Specificity | There should not be any peaks of Blank, Placebo at main peak retention time | There is no any peak of Blank, Placebo at main peak retention time. |
2. | System Accuracy | ||
Tailing Factor | Not More Than 2.0
|
1.05 | |
% Relative standard deviation | Not More Than 2.0 | 0.1 % | |
3 | Linearity
Coefficient of Correlation (r) Linearity concentration verses detector response (area) |
Not Less Than 0.99 | 0.99202
|
4 | Range
(80 % to 120 % of assay concentration) |
Should be Linear | Linear |
5 | Accuracy
% Relative standard deviation |
Not More Than 2.0 |
0.10% |
6 | Precision | ||
System Precision | |||
% Relative standard deviation | Not More Than 2.0 | 0.30% | |
(i) Method Precision | |||
% Relative standard deviation | Not More Than 2.0 | 1.32% | |
(ii) Intermediate Precision | |||
% Relative standard deviation | Not More Than 2.0 | 1.34% | |
Overall % Relative standard deviation | Not More Than 2.0 | 1.45% | |
7 | Robustness | ||
For flow rate 0.8 ml/min | |||
Tailing Factor | Not More Than 2.0
|
1.0 | |
Theoretical Plates | Not Less Than 2000 | 16236.7 | |
For flow rate 1.0 ml/min | |||
Tailing Factor | Not More Than 2.0
|
1.0 | |
Theoretical Plates | Not Less Than 2000 | 14770.0 | |
For flow rate 1.2 ml/min | |||
Tailing Factor | Not More Than 2.0
|
1.0 | |
Theoretical Plates | Not Less Than 2000 | 12950.6 | |
For mobile phase water (20%) : Methanol (80%) | |||
Tailing Factor | Not More Than 2.0
|
1.0 | |
Theoretical Plates | Not Less Than 2000 | 17448.7 | |
For mobile phase water (15%) : Methanol (85%) | |||
Tailing Factor | Not More Than 2.0
|
1.0 | |
Theoretical Plates | Not Less Than 2000 | 14542.9 | |
For mobile phase water (25%) : Methanol (75%) | |||
Tailing Factor | Not More Than 2.0
|
1.0 | |
Theoretical Plates | Not Less Than 2000 | 12733.6 |
- SPECIFICITY:
Check the interference of diluents and placebo (as preservatives) by individual injections
Blank: as methanol
Placebo Preparation:
A placebo solution was prepared same as the formulation except for the addition of the active ingredients. Here, the product contains no inactive ingredients. So, here the diluents are used as the placebo solution. Area at 271 nm, Observation Result: Nil
Conclusion for Specificity:
We observed that at wavelength 271 nm there is no significant area for Blank and placebo at main peak of Aceclofenac & Paracetamol. And inject the different dilution of Aceclofenac & Paracetamol ws for better clarity to identify the peaks of both. Therefore specificity of the method considered acceptable.
2. SYSTEM ACCURACY:
The system precision of the above method was carried out by taking area for six injection of the standard preparation of exact weight. Text data collection sheet:
Serial No. | Area of Aceclofenac | Assay of Paracetamol |
1. | ||
2. | ||
3. | ||
4. | ||
5. | ||
Mean | ||
% RSD |
Acceptance Criteria: RSD is not more than 2.0%
3, 4, 5. LINEARITY, RANGE AND ACCURACY:
(i)Linearity:
Linearity can be defined as the response of an analytical method conducted as a function for the analyse concentration. In other words, it is the response of an analytical method in proportion to the concentration of analyse in samples.
Linearity can be evaluated by visual inspection of a plot of signals / response as a function of analyte concentration of content. Correlation Coefficient not less than 0.99.
(ii)Range:
The Range of an analytical method is the interval between the upper & lower level of analyte that have been demonstrated with precision, accuracy & linearity using the method as written. The Range is normally expressed in same units as test results e.g. Percent or Parts per million, obtained by the analytical method. All five concentrations (80, 100, and 120 in per cent) will be considered for the linearity and range of the method will be 40 to 60ppm.
(iii)Accuracy:
It describes the deviation from the standard or expected result.
The accuracy of an analytical procedure expresses the closeness of agreement between the value, which is accepted either as a conventional true value or as an accepted reference value and the value found.
The accuracy of method is determined by recovery experiment. The recovery is performed by adding Aceclofenac+Paracetamol tablets standard at five different concentration (40, 45, 50, 55, 60ppm) levels to placebo (excipients mixture) in the range of test concentration.
Text data collection sheet:
Sr. No. | Standards | Area of Aceclofenac | Assay of Paracetamol |
1. | Standard-1 | ||
2. | Standard-2 | ||
3. | Standard-3 | ||
4. | Standard-4 | ||
5. | Standard-5 | ||
6. | Mean | ||
7. | %RSD |
Acceptance Criteria: RSD is not more than 2.0%
Samples | Area of Aceclofenac | Mean | Area of Paracetamol | Mean | |
A-01 80% |
|
|
|||
A-02 80% | |||||
A-03 80% | |||||
C-01 100% | |||||
C-02 100 % | |||||
C-03 100 % | |||||
E-01 120% | |||||
E-02 120 % | |||||
E-03 120 % |
Concentration (mg/ml) | Conc.
in % |
Mean area | % Recovery | Corr. Coefficient
(area/recovery) |
Aceclofenac | Aceclofenac | Aceclofenac | Aceclofenac | |
16 | 80 | |||
20 | 100 | |||
24 | 120 |
Concentration (%) Recovery%
80 81.47
100 98.46
120 114.44
Concentration (mg/ml) | Conc.
in % |
Mean area | % Recovery | Corr. Coefficient
(area/recovery) |
Paracetamol | Paracetamol | Paracetamol | Paracetamol | |
16 | 80 |
Area- 0.99302 Recovery- 0.9980
|
||
20 | 100 | |||
24 | 120 |
Linearity graph plot of Paracetamol :
Concentration (%) Recovery%
80 81.53
100 98.49
120 119.74
Linearity graph plot of Aceclofenac:
Linearity graph plot of Paracetamol :
Linearity graph plot of Aceclofenac:
Concentration (%) Recovery%
80 81.47
100 98.46
120 114.44
Linearity graph plot of Paracetamol:
Concentration (%) Area
80 16521460.3
100 20263820
120 24263801.6
R-squared value (R2): The R-squared value, also known as the coefficient of determination, is an indicator that ranges in value from 0 to 1 and reveals how closely the estimated values for the trend line correspond to your actual data. A trend line is most reliable when its R-squared value is at or near 1.
Linearity Equation
Equations for calculating trend line
Calculates the least squares fit for a line represented by the following equation:
y = m x + b
Where m is the slope and b is the intercept.
x = concentration
y = Area Value
Sample
Therefore, from Linearity Equation, y = mx + b, m 0.999x
b 0.163
Conclusion for Linearity:
The graphical representation & data collected during this exercise proves Aceclofenac and Paracetamol for demonstrate linearity in the range of 80% to 120% when determined by HPLC.
6. PRECISION-
6. (i) METHOD PRECISION:
(i) Analyst (I): Dinesh Kumar–
Sample Dilutions:
(A) Take about 404.3mg of the sample and proceed as per above.
(B) Take about 405.2mg of the sample and proceed as per above.
(C) Take about 405.5mg of the sample and proceed as per above.
(D) Take about 405.3mg of the sample and proceed as per above.
(E) Take about 405.4mg of the sample and proceed as per above.
(F) Take about 405.4mg of the sample and proceed as per above.
Test Data Collection:-
Sr. No. | Standards | Area of Aceclofenac | Area of Paracetamol | |||||
1. | Standard-1 | |||||||
2. | Standard-2 | |||||||
3. | Standard-3 | |||||||
4. | Standard-4 | |||||||
5. | Standard-5 | |||||||
6. | Mean | 4650378.6 | 12535673.2 | |||||
7. | %RSD | 0.23 | 0.30 | |||||
Acceptance Criteria: RSD is not more than 2.0% | ||||||||
Samples | Sample Area | Sample Area | Mean | Mean | ||||
Aceclofenac | Paracetamol | Aceclofenac | Paracetamol | |||||
A | T1 | 3805553 | 10251267 | 3800378.5 | 10237086 | |||
T2 | 3795204 | 10222905 | ||||||
B | T1 | 3762973 | 10176399 | 3781116.5 | 10196259.5 | |||
T2 | 3799260 | 10216120 | ||||||
C | T1 | 3766156 | 10178710 | 3783837 | 10205700 | |||
T2 | 3801518 | 10232690 | ||||||
D | T1 | 3778423 | 10215079 | 3790844.5 | 10206685 | |||
T2 | 3803266 | 10198291 | ||||||
E | T1 | 3801525 | 10208390 | 3794786 | 10216069 | |||
T2 | 3788047 | 10223748 | ||||||
F | T1 | 3806593 | 10214874 | 3788029 | 10212701.5 | |||
T2 | 3769465 | 10210529 | ||||||
Table for Six Replicate Assays: Aceclofenac 100mg
Sample Number | Estimated % Amount | Mean | RSD |
Aceclofenac | Aceclofenac | Aceclofenac | |
Sample A |
100.384% |
100.122 % |
1.12% |
Sample B | 99.949 % | ||
Sample C | 99.947 % | ||
Sample D | 100.19 % | ||
Sample E | 100.22% | ||
Sample F | 100.045% |
Table for Six Replicate Assays: Paracetamol 350mg
Sample Number | Estimated % Amount | Mean | RSD |
Paracetamol | Paracetamol | Paracetamol | |
Sample A |
100.493% |
100.228 % |
1.10% |
Sample B | 99.968% | ||
Sample C | 99.944% | ||
Sample D | 100.85% | ||
Sample E | 100.075% | ||
Sample F | 100.042% |
Acceptance Criteria: NMT 2% (% of Relative Standard Deviation)
Conclusion for precision:
The overall % Relative standard deviation for 1.12% respectively of Aceclofenac and Paracetamol in tablets, there is no significant difference. Therefore Repeatability of the method considered acceptable as it well within 2 % Relative Standard Deviation.
- (ii) INTERMEDIATE PRECISION:
(Within laboratory variations such as different days, analyst & equipments):
(ii) Analyst (II): –
Sample Dilutions:
(A) Take 5.0368gm of the sample and proceed as per above.
(B) Take 5.0654gm of the sample and proceed as per above.
(C) Take 5.0373gm of the sample and proceed as per above.
(D) Take 5.0551gm of the sample and proceed as per above.
(E) Take 5.0373gm of the sample and proceed as per above.
(F) Take 5.0320gm of the sample and proceed as per above.
Test Data Collection:-
Sr. No. | Standards | Area of Aceclofenac | Area of paracetamol | |||||
1. | Standard-1 | 4627069 | 12527057 | |||||
2. | Standard-2 | 4676479 | 12602272 | |||||
3. | Standard-3 | 4658172 | 12541237 | |||||
4. | Standard-4 | 4654081 | 12507089 | |||||
5. | Standard-5 | 4636092 | 12500711 | |||||
6. | Mean | 4650378.6 | 12535673.2 | |||||
7. | %RSD | 0.23 | 0.30 | |||||
Acceptance Criteria: RSD is not more than 2.0%
|
||||||||
Samples | Sample Area | Sample Area | Mean | Mean | ||||
Aceclofenac | Paracetamol | Aceclofenac | Paracetamol | |||||
A | T1 | 3816972 | 10222430 | 3794098 | 10212870.5 | |||
T2 | 3771224 | 10203311 | ||||||
B | T1 | 3804314 | 10193938 | 3791808 | 10184115 | |||
T2 | 3779302 | 10174292 | ||||||
C | T1 | 3804414 | 10143064 | 3784826.5 | 10180360 | |||
T2 | 3765239 | 10217656 | ||||||
D | T1 | 3771454 | 10190342 | 3782254 | 10195864 | |||
T2 | 3793054 | 10201386 | ||||||
E | T1 | 3767640 | 10198919 | 3786835.5 | 10208185.5 | |||
T2 | 3806031 | 10217452 | ||||||
F | T1 | 3760595 | 10177601 | 3768631.5 | 10199051.5 | |||
T2 | 3776668 | 10220502 | ||||||
Table for Six Replicate Assays:
Sample Number | Estimated % Amount | Estimated % Amount | Mean | RSD | RSD | |
Aceclofenac | Paracetamol | Aceclofenac | Paracetamol | Aceclofenac | Paracetamol | |
Sample A | 99.541 % | 99.762% |
99.849 % |
100.208%
|
1.34% |
1.25%
|
Sample B | 100.147% | 100.048% | ||||
Sample C | 100.16% | 100.21% | ||||
Sample D | 99.722% | 99.99% | ||||
Sample E | 99.892% | 100.52% | ||||
Sample F | 99.633% | 100.29% |
Acceptance Criteria: NMT 2% (% of Relative Standard Deviation)
Conclusion for precision:
The overall % Relative standard deviation for 1.34% respectively of Aceclofenac and Paracetamol in Tablets, there is no significant difference. Therefore Repeatability of the method considered acceptable as it well within 2 % Relative Standard Deviation.
Table for Six Replicate Assays analyst by two different Analysts & days:
Test Data analyst by :-
Table for Six Replicate Assays:
Sample Number | Estimated % Amount | % Amount | Mean | Mean | RSD | RSD |
Aceclofenac | Paracetamol | Aceclofenac | Paracetamol | Aceclofenac | Paracetamol | |
Sample A | 101.89 % |
101.635 % |
|
1.32% |
||
Sample B | 101.96 % | |||||
Sample C | 103.20 % | |||||
Sample D | 102.39 % | |||||
Sample E | 99.28 % | |||||
Sample F | 101.09 % |
Test Data analyst by :-
Table for Six Replicate Assays:
Sample Number | Estimated % Amount | % Amount | Mean | Mean | RSD | RSD |
Aceclofenac | Paracetamol | Aceclofenac | Paracetamol | Aceclofenac | Paarcetamol | |
Sample A | 100.10 % |
|
101.12 % |
|
1.34% |
|
Sample B | 98.93 % | |||||
Sample C | 101.73 % | |||||
Sample D | 102.51 % | |||||
Sample E | 101.33 % | |||||
Sample F | 102.09 % |
Acceptance Criteria: NMT 2% (% of Relative Standard Deviation).
Conclusion for Intermediate Precision:
The overall % Relative standard deviation of two different analysts is 1.32% & 1.34% respectively of Aceclofenac & Paracetamol Tablets there is no significant difference between two analysts within laboratory variations such as different days, analyst & equipments. Therefore reproducibility of the method considered to be acceptable.
- ROBUSTNESS:
The robustness of an analytical method should show the reliability of an analysis with respect to deliberate variations in method parameters. The variation used for the study are:
- Change in ratio of the mobile phase. Record the observation in below observation table.
- Change in Flow rate of mobile phase. Record the observation in below observation table.
Observation Table:-
Change ratio in the mobile phase at 296nm
Mobile Phase | Flow rate (ml/min) | System suitability | |||
Water | Acetonitrile | Retention Time | Theoretical Plates | Tailing Factor | |
500ml | 500ml | 1.0 ml/min | 12.001 | 17448.7 | 1.0 |
450ml | 550ml | 1.0 ml/min | 8.577 | 14542.9 | 1.0 |
400ml | 600ml | 1.0 ml/min | 6.612 | 12733.6 | 1.0 |
Change in flow rate at 296nm | |||||
Mobile Phase | Flow rate (ml/min) | System suitability | |||
Water | Acetonitrile | Retention Time | Theoretical Plates | Tailing Factor | |
450ml | 550ml | 0.8 ml/min | 10.599 | 16236.7 | 1.0 |
450ml | 550ml | 1.0 ml/min | 8.561 | 14770.0 | 1.0 |
450ml | 550ml | 1.2 ml/min | 7.141 | 12950.6 | 1.0 |
Acceptance criteria:
Analytical method validation shall be robust (i.e. Theoretical Plates is not less than 2000 & tailing factor is not more than 2.0).
Conclusion for Robustness:
There is no significant difference for Fexofinadine & Montelukast in Fexolock-M Tablets for different conditions, such as composition & Flow rate of mobile phase. Therefore Robustness of the method considered acceptable.
- CONCLUSION:
All the analytical parameter are checked as per the approved validation process and found well within specified acceptance criteria. Hence, it is concluded that, this method is suitable for accurate & precise results for routine analysis.
***